The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...

The Advertising Standards Authority said misleading claims could give false reassurance or make it harder to know when to ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

Watchdog bans ads for at-home prostate cancer testing kits and supplements - The advertising watchdog exposed one ad for ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy procedure.

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.

“Authorization of our full screening portfolio by the Egyptian Drug Authority represents a milestone in expanding access to early detection in a region with growing chronic disease and cancer burdens, ...

Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s IsoPSA® in vitro ...

Cleveland Diagnostics is preparing to roll out its newly approved prostate cancer test kit in early 2026, with plans to ...

The NHS will not be inviting all men over a certain age to be checked for prostate cancer like it does for some other cancers. The UK National Screening Committee has recommended that the prostate ...